Why Atara Biotherapeutics Stock Is Sinking Today. A fatality in an early-stage clinical trial is weighing on the cell therapy company's stock today. George. Atara Biotherapeutics Inc ; May, Downgrade, Citigroup, Buy → Neutral, $15 → $8 ; May, Upgrade, JP Morgan, Neutral → Overweight, $23 → $ Atara Biotherapeutics, Inc. (Symbol: ATRA) is a pioneering company in the healthcare sector, specializing in the development of transformative therapies for. Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune. ATRA Stock. Charts. ATRA Stock. Overview · Charts · Historical Data · FAQ · Classification Info. Charting. Atara Biotherapeutics Inc. Nasdaq Global Select: ATRA.
Is Atara Biotherapeutics stock A Buy? Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold. Atara Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ATRA updated stock price target summary. ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Atara Biotherapeutics, Inc. Stock ; Sector. Biotechnology & Medical Research ; Calendar. - H.C. Wainwright Global Investment Conference ; Mean consensus. About Atara Biotherapeutics, Inc. Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat. View Atara Biotherapeutics Inc ATRA stock quote prices, financial information, real-time forecasts, and company news from CNN. Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change View the latest Atara Biotherapeutics Inc. (ATRA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Track Atara Biotherapeutics Inc (ATRA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform. See the latest Atara Biotherapeutics Inc stock price (ATRA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
View the ATRA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Atara Biotherapeutics. Find the latest Atara Biotherapeutics, Inc. (ATRA) stock quote, history, news and other vital information to help you with your stock trading and investing. In the current month, ATRA has received 4 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. ATRA average Analyst price target in the past 3 months is $ Stock analysis for Atara Biotherapeutics Inc (AT2:GR) including stock price, stock chart, company news, key statistics, fundamentals and company profile. News & Events, Financial Results, ATRA Stock Analyst Coverage, SEC Filings, Governance, Careers, Careers Home, Career Areas, Job Search, Contact. Research Atara Biotherapeutics' (Nasdaq:ATRA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. Discover real-time Atara Biotherapeutics, Inc. Common Stock (ATRA) stock prices, quotes, historical data, news, and Insights for informed trading and. Atara Biotherapeutics is traded on the NASDAQ stock exchange under the symbol “ATRA”. When did Atara Biotherapeutics go public? Atara Biotherapeutics went. Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule (c)(4) · Atara Biotherapeutics to Participate in the H.C. Wainwright 26th.
Fair Value of ATRA stock based on Discounted Cash Flow (DCF) ATRA ($) is overvalued by subscribe to Premium to read more. ATRA ($) is not. 56 minutes ago. As of Aug the stock price of Atara Biotherapeutics is $ What is the current market cap of Atara Biotherapeutics? The current market capitalization. Thinking of buying or selling Atara Biotherapeutics Inc stock that's listed in a currency different from your local one? Use our international stock ticker. The stock price for Atara Biotherapeutics (NASDAQ: ATRA) is $ last updated September 5, at PM EDT. Q. Does Atara Biotherapeutics (ATRA) pay a.
Atara Biotherapeutics, Inc NASDAQ: ATRA is an allogeneic T-cell immunotherapy company leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell. Stock Range ; Today's Range. Low: ; 52 Week Range. Low: ; Liquidity liquidity info. Low. ATRA Atara Biotherapeutics, Inc. Stock Price & Overview ; Capital Structure. Market Cap. $M · Total Debt. $M · Cash. $M · Other. -. Enterprise Value. On average, Wall Street analysts predict that Atara Biotherapeutics's share price could reach $ by Aug 16, The average Atara Biotherapeutics stock. Atara Biotherapeutics Inc price ; Market Cap. M ; Volume (3M). M ; Price-Earnings Ratio. ; Revenue. M. Learn more about Atara Biotherapeutics Inc's (ATRA) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether this Biotechnology &.